clinical trials

News

Newron charts course forward for stalled schizophrenia drug

Newron thinks it may have reached an agreement with the FDA on a way to get the US development of its schizophrenia candidate evenamide back on track.

R&D

HCP and electronic clinical outcome assessments

Why are eCOA studies still so challenging?

Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.

News

Roche's KRAS drug tops its rivals in lung cancer trial

Roche has thrown down the gauntlet to Amgen and Bristol Myers Squibb with new phase 3 data for its experimental KRAS G12C inhibitor, divarasib.

News

Digital brain inside human head concept for Vistagen

Despite study bust, Vistagen still hopes to file anxiety dru...

Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.

News

Drugmakers asked to defend Chinese trials; reports

The House China Select Committee has quizzed MSD, AbbVie, Bristol Myers Squibb, and Pfizer about the ethics of clinical trials run in China.

News

Brukinsa data raises chemo-free hope for mantle cell lymphom...

Patients with newly diagnosed mantle cell lymphoma could avoid chemotherapy with a regimen based on BeOne's Brukinsa, according to the MANGROVE trial.

Newron charts course forward for stalled schizophrenia drug

Why are eCOA studies still so challenging?

Roche's KRAS drug tops its rivals in lung cancer trial

Despite study bust, Vistagen still hopes to file anxiety dru...

Drugmakers asked to defend Chinese trials; reports

Brukinsa data raises chemo-free hope for mantle cell lymphom...

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks